Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion.

[1]  M. Humbert,et al.  2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2022, European Respiratory Journal.

[2]  M. Metra,et al.  Evolution of tricuspid regurgitation after transcatheter edge‐to‐edge mitral valve repair for secondary mitral regurgitation and its impact on mortality , 2022, European journal of heart failure.

[3]  H. Thiele,et al.  Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair. , 2022, Journal of the American College of Cardiology.

[4]  A. Bagai,et al.  Outcomes of Transcatheter Edge-to-Edge Repair, Surgical and Medical Therapy in Combined Mitral and Tricuspid Regurgitation. , 2022, JACC. Cardiovascular interventions.

[5]  OUP accepted manuscript , 2022, European Heart Journal.

[6]  D. Burkhoff,et al.  Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations , 2021, Circulation. Heart failure.

[7]  M. Mack,et al.  Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. , 2021, The New England journal of medicine.

[8]  B. Prendergast,et al.  Transcatheter treatment for tricuspid valve disease. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  Jeroen J. Bax,et al.  Right Ventricular-Pulmonary Arterial Coupling in Patients With HF Secondary MR: Analysis From the COAPT Trial. , 2021, JACC. Cardiovascular interventions.

[10]  E. Chung,et al.  Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation , 2021, ESC heart failure.

[11]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[12]  S. Zimmer,et al.  Leaflet Configuration and Residual Tricuspid Regurgitation after Transcatheter Edge-to-Edge Tricuspid Repair. , 2021, JACC. Cardiovascular interventions.

[13]  H. Thiele,et al.  Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosis , 2021, European journal of heart failure.

[14]  M. Metra,et al.  Percutaneous edge-to-edge mitral valve repair: beyond the left heart. , 2021, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  B. Prendergast,et al.  Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation , 2021, Heart.

[16]  U. Benedetto,et al.  The best approach for functional tricuspid regurgitation: A network meta‐analysis , 2021, Journal of cardiac surgery.

[17]  G. Nickenig,et al.  Fate of Tricuspid Regurgitation in Patients Undergoing Transcatheter Edge-to-Edge Mitral Valve Repair. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[18]  M. Guazzi,et al.  Non-response to acute vasodilator challenge and prognosis in heart failure with pulmonary hypertension. , 2021, Journal of cardiac failure.

[19]  M. Mack,et al.  Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation. , 2021, Journal of the American College of Cardiology.

[20]  C. Butter,et al.  Natural course of tricuspid regurgitation and prognostic implications , 2021, Open Heart.

[21]  J. Hausleiter,et al.  Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation. , 2021, Journal of the American College of Cardiology.

[22]  T. Münzel,et al.  Concomitant tricuspid regurgitation severity and its secondary reduction determine long-term prognosis after transcatheter mitral valve edge-to-edge repair , 2021, Clinical Research in Cardiology.

[23]  W. Gray,et al.  Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation: 30-Day Outcomes. , 2021, JACC. Cardiovascular interventions.

[24]  M. Mack,et al.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[25]  H. Thiele,et al.  Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure. , 2020, JACC. Cardiovascular interventions.

[26]  L. Badano,et al.  Right atrial volume is a major determinant of tricuspid annulus area in functional tricuspid regurgitation: a three-dimensional echocardiographic study. , 2020, European heart journal cardiovascular Imaging.

[27]  J. Hausleiter,et al.  Two-year Outcomes with the Cardioband Tricuspid System from the Multicentre, Prospective TRI-REPAIR Study. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[28]  M. Mack,et al.  Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial. , 2020, Journal of the American College of Cardiology.

[29]  M. Guazzi,et al.  Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.

[30]  M. Obokata,et al.  Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.

[31]  M. Metra,et al.  Transcatheter therapies for tricuspid valve regurgitation , 2020, Journal of cardiovascular medicine.

[32]  Jeroen J. Bax,et al.  Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient‐level database analysis , 2020, European journal of heart failure.

[33]  Shao‐Wei Chen,et al.  Late Outcomes of Valve Repair Versus Replacement in Isolated and Concomitant Tricuspid Valve Surgery: A Nationwide Cohort Study , 2020, Journal of the American Heart Association.

[34]  H. Michelena,et al.  Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival. , 2020, European heart journal.

[35]  J. Lessick,et al.  Risk Factors for the Development of Functional Tricuspid Regurgitation and Their Population-Attributable Fractions. , 2020, JACC. Cardiovascular imaging.

[36]  P. Boekstegers,et al.  Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe Mitral and Tricuspid Regurgitation: An Analysis From the TriValve and TRAMI Registries. , 2020, JACC. Cardiovascular interventions.

[37]  H. Thiele,et al.  Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. , 2019, European heart journal.

[38]  H. Thiele,et al.  Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience. , 2019, JACC. Cardiovascular interventions.

[39]  Jeroen J. Bax,et al.  Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation. , 2019, Journal of the American College of Cardiology.

[40]  J. Hausleiter,et al.  Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study , 2019, The Lancet.

[41]  P. Blanke,et al.  Novel Transcatheter Mitral Valve Prosthesis for Patients With Severe Mitral Annular Calcification. , 2019, Journal of the American College of Cardiology.

[42]  K. Kuck,et al.  1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry. , 2019, JACC. Cardiovascular interventions.

[43]  J. Leipsic,et al.  Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience. , 2019, JACC. Cardiovascular interventions.

[44]  S. Bolling,et al.  Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease. , 2019, JACC. Cardiovascular imaging.

[45]  M. Enriquez-Sarano,et al.  Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. , 2019, JACC. Cardiovascular imaging.

[46]  S. Rosenkranz,et al.  Pulmonary hypertension due to left heart disease , 2019, European Respiratory Journal.

[47]  A. Pasquet,et al.  Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery†. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[48]  Jeroen J. Bax,et al.  Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history , 2018, European heart journal.

[49]  H. Thiele,et al.  Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk. , 2018, JACC. Cardiovascular interventions.

[50]  H. Thiele,et al.  Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. , 2018, JACC. Cardiovascular interventions.

[51]  M. Hutyra,et al.  Macitentan in pulmonary hypertension due to left ventricular dysfunction , 2018, European Respiratory Journal.

[52]  F. Fernández‐Avilés,et al.  Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial , 2017, European heart journal.

[53]  J. Mehilli,et al.  Transcatheter Treatment of Severe Tricuspid Regurgitation Using the Edge-to-Edge Repair Technique in the Presence and Absence of Pacemaker Leads. , 2017, JACC. Cardiovascular interventions.

[54]  J. Hausleiter,et al.  The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair? , 2017, JACC: Cardiovascular Interventions.

[55]  R. Siegel,et al.  Postprocedural Changes of Tricuspid Regurgitation After MitraClip Therapy for Mitral Regurgitation. , 2017, The American journal of cardiology.

[56]  N. Moat,et al.  Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis. , 2017, International journal of cardiology.

[57]  O. Alfieri,et al.  Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique , 2017, Circulation.

[58]  J. Schofer,et al.  Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[59]  E. Agricola,et al.  Effects of functional tricuspid regurgitation on renal function and long-term prognosis in patients with heart failure , 2017, Journal of cardiovascular medicine.

[60]  J. Mehilli,et al.  Transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[61]  M. Bahls,et al.  Cachexia and right ventricular dysfunction in chronic heart failure: what is the chicken and what the egg? , 2016, European heart journal.

[62]  F. Ruschitzka,et al.  Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[63]  G. Nickenig,et al.  Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. , 2016, European heart journal.

[64]  P. Boekstegers,et al.  One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry , 2015, European heart journal.

[65]  D. Adams,et al.  Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. , 2015, Journal of the American College of Cardiology.

[66]  D. Capodanno,et al.  Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. , 2014, European heart journal cardiovascular Imaging.

[67]  R. Nishimura,et al.  The Hemodynamic Basis of Exercise Intolerance in Tricuspid Regurgitation , 2014, Circulation. Heart failure.

[68]  E. Blackstone,et al.  Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure. , 2013, The Journal of thoracic and cardiovascular surgery.

[69]  N. Westerhof,et al.  Accurate assessment of load-independent right ventricular systolic function in patients with pulmonary hypertension. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[70]  E. Agricola,et al.  Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction , 2012, European journal of heart failure.

[71]  G. Melina,et al.  Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery. , 2012, The Journal of thoracic and cardiovascular surgery.

[72]  F. Hornero,et al.  Factors for development of late significant tricuspid regurgitation after mitral valve replacement: the impact of subvalvular preservation. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[73]  B. Lytle,et al.  Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? , 2010, The Journal of thoracic and cardiovascular surgery.

[74]  M. Ruel,et al.  Clinical and echocardiographic impact of functional tricuspid regurgitation repair at the time of mitral valve replacement. , 2009, The Annals of thoracic surgery.

[75]  Jong-Min Song,et al.  Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery , 2009, Heart.

[76]  S. Gallina,et al.  Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? a propensity score analysis. , 2009, The Annals of thoracic surgery.

[77]  A. Shiran,et al.  Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. , 2009, Journal of the American College of Cardiology.

[78]  Young‐Bae Park,et al.  Development of tricuspid regurgitation late after left-sided valve surgery: a single-center experience with long-term echocardiographic examinations. , 2008, American heart journal.

[79]  M. Antunes,et al.  Management of tricuspid valve regurgitation , 2005, Heart.

[80]  David H Adams,et al.  A three-dimensional ring annuloplasty for the treatment of tricuspid regurgitation. , 2006, The Annals of thoracic surgery.

[81]  C. Duran,et al.  Progression of Tricuspid Regurgitation After Repaired Functional Ischemic Mitral Regurgitation , 2005, Circulation.

[82]  G. Dreyfus,et al.  Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? , 2005, The Annals of thoracic surgery.

[83]  Jeevanantham Rajeswaran,et al.  Tricuspid valve repair: durability and risk factors for failure. , 2004, The Journal of thoracic and cardiovascular surgery.

[84]  Jayant Nath,et al.  Impact of tricuspid regurgitation on long-term survival. , 2004, Journal of the American College of Cardiology.

[85]  Jagmeet P. Singh,et al.  Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) , 1999, The American journal of cardiology.

[86]  B. Gersh,et al.  Surgery for tricuspid regurgitation late after mitral valve replacement. , 1984, Circulation.

[87]  A. Carpentier,et al.  Surgical management of acquired tricuspid valve disease. , 1974, The Journal of thoracic and cardiovascular surgery.